Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Virginia L. Stauffer, PharmD
JCP
Original Research
Noradrenergic Symptom Cluster and MDD
March 29, 2017
Adding an SNRI may improve impaired cognition and fatigue, and hence improve the overall depression outcome in patients with partial response to an SSRI. This analysis of trials of...
Virginia L. Stauffer
,
Peng Liu
,
Celine Goldberger
, et al
JCP
Original Research
Analysis of Gene Variants Previously Associated With Iloperidone Response in Patients With Schizophrenia Who Are Treated With Risperidone
July 12, 2011
Bonnie A. Fijal
,
Virginia L. Stauffer
,
Bruce J. Kinon
, et al
JCP
Original Research
A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia
March 24, 2009
John M. Kane
,
Olawale Osuntokun
,
Ludmila A. Kryzhanovskaya
, et al
JCP
Letter to the Editor
What Do We Know About Insulin Resistance and Glucose Metabolism in Patients With Schizophrenia Treated With Antipsychotics?
May 15, 2007
Jamie Karagianis
,
Vicki Poole Hoffmann
,
Virginia L. Stauffer
, et al
JCP
Original Research
Strategies for Switching From Conventional Antipsychotic Drugs or Risperidone to Olanzapine
October 31, 2000
Bruce J. Kinon
,
Bruce R. Basson
,
Julie A. Gilmore
, et al
